ASTH

Astrana Health INC

+$16.5M

Net Activity

Institutions Holding

171

Popularity Rank

#3272

Avg Weight

0.13%

Total Value

$740.5M

Ownership Trend

171 institutions currently hold ASTH, with 87 net buyers and 80 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Neutral

Based on recent trading activity

Net Selling Institutions

80

Net Buying Institutions

87

Key Holders

View all 171 holding institutions

Quarterly Activity

Recent Activity

+$442.4M

Total Buy Value

$192.7M

Total Sell Value

New buy20
Trim52
Add67
Sold out28

87

Net Buyers

80

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

2

Filings (14d)

Data as of 2026-07-13
2026-07-13

Astrana Health, Inc. issued a press release on July 13, 2026, regarding the performance of its accountable care organizations (ACOs) in 2024. The release is attached as Exhibit 99.1 to this Form 8-K and is furnished, not filed, under securities laws.

View Full Filing (SEC EDGAR)
2026-07-01

Astrana Health, Inc. announced the retirement of Chief Accounting Officer Glenn Sobotka, effective August 7, 2026. John Vong, who previously held the same role at the company from 2022 to 2025, will succeed him. Starting July 1, 2026, Vong's annual base salary will increase to $320,000.

View Full Filing (SEC EDGAR)

View all Form 8-K filings

FAQ

Who are the top institutional investors holding ASTRANA HEALTH INC (ASTH)?
Major stakeholders currently include BlackRock, Inc. ($151.1M), Vanguard Portfolio Management LLC ($55.8M), 325 Capital LLC ($45.1M). Based on the latest 13F filings, there are a total of 171 tracked investment funds and institutions maintaining positions in ASTH.
What is the overall institutional sentiment toward ASTH recently?
Institutional sentiment appears Bullish (Net Buying). During the most recent reporting quarter, the stock experienced a net inflow of $16.5M, driven by 87 managers accumulating shares while 80 reduced their exposure.
Which institutions have been selling or reducing their ASTH positions?
In the latest period, 52 funds trimmed their holdings, and 28 managers completely exited their positions. The aggregate reported sell value was $192.7M.
Are there any notable investors adding ASTH to their portfolios?
Yes, buying activity remains notable. 20 institutions opened new positions in {ticker}, and 67 existing holders added to their shares. The total reported buy value for the quarter amounted to $442.4M.

Related Stocks